Skip to main content

Reimbursement

07
May 2020

German DRG system change in 2020

Since January 1, 2020, the nursing staff costs of the hospitals are excluded from the DRG case flat rates and financed in parallel to the DRG case flat rates using a hospital-specific care budget based on the principle of cost coverage.
06
May 2020

The DRG changes in Norway in 2020

MTRC has summarized the most important DRG changes in Norway, which came in force in 2020. This includes five new DRGs, one deleted DRG, changes in the titles of four DRGs and other changes.
28
Apr 2020

Thirteen new procedure codes added to private reimbursement schedule in England

The Clinical Coding and Schedule Development (CCSD) group develops and maintains procedural and diagnostics nomenclature for private payers in England. New procedure codes concern pediatric cataract involving lensectomy with or without lens implant, pediatric cataract involving lens aspiration and implant, delivery of a fraction MR Linac adaptive planned radiotherapy, low-level laser therapy for inflammation/pain relief and others. The codes are introduced with a recommended adoption date being the 1st of May 2020. The documents also contain a list of textual changes in codes and unacceptable combinations.
21
Apr 2020

Block contract payments until 31 July in NHS England

On 17 March 2020, NHS England announced that block contracts would be used to cover the period 1 April – 31 July, as the national tariff is suspended. Contractual arrangements for 2020/21 with NHS trusts/NHS foundation trusts and with non-NHS providers operating under the NHS Standard Contract were published.
20
Apr 2020

Belgian INAMI/RIZIV updated the List of reimbursable implants and medical devices

New material codes for a locking stylus for extraction of endovenous electrodes and system with recovery lasso for the extraction of endovenous electrodes by femoral approach were added to the List of reimbursable devices of the Belgian National Institute for Health and Disability Insurance (INAMI-RIZIV) in April 2020. Some reimbursement conditions were updated as well.
16
Apr 2020

Glioblastoma therapy with tumor-treating fields will be available in Germany

Patients with a newly diagnosed glioblastoma will have an opportunity to benefit from the therapy with tumor-treating fields (TTF) at the expense of statutory health insurance. The Federal Joint Committee (G-BA) decided on March 20, 2020, the details concerning the indications and the quality assurance measures that will apply when prescribing this outpatient treatment method.